drugset / Trial / NCT01188486

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

NCT01188486

Terminated 12 enrolled Stanford University
NaSingle-groupOpen-labelDevice feasibility

Summary

The stereotactic body radiation therapy (SBRT) procedure is an emerging alternative to the standard treatment for early stage non-small cell lung cancer (NSCLC), typically lobectomy with lymphadenectomy. This procedure (lobectomy) does not fulfill the medical need as many patients are poor operative candidates or decline surgery. This study assesses the feasibility of stereotactic body radiation therapy (SBRT) as a tool to produce therapeutically useful computed tomography (CT) scans, using standard water-soluble iodinated compounds as the contrast agents.

Timeline

Start
2010-08
Primary completion
2017-04-30
Completion
2017-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Iodixanol Diagnostic / imaging agent Other
Subject Iohexol Diagnostic / imaging agent Other